Want the eyeballs of people with obesity? Think TV. That is a takeaway from a CMI survey that suggests the fight for ...

As more United States drug price changes have come to light this month, it remains clear that companies are tamping down ...

Roche’s freshly approved PI3K inhibitor Itovebi can help extend the lives of certain patients with breast cancer when used in ...

When Novo Nordisk unveiled kidney outcomes data for its star GLP-1 medicine Ozempic last May, the company’s executive medical ...

Telehealth company Hims & Hers is playing offense in a new commercial slated to air during the Super Bowl next month. | Telehealth company Hims & Hers is playing offense in a new commercial slated to ...

The Trump administration’s executive order pausing foreign aid programs has sent crash waves through relief organizations ...

Just 11 days after AstraZeneca and Daiichi Sankyo gained FDA approval | The FDA has cleared AstraZeneca and Daiichi Sankyo's ...

On a quest to carve out a spot as one of the nuclear medicine greats, Massachusetts-based radiopharmaceutical specialist ...

As Sandoz gears up to launch one of the most anticipated biosimilars of the year, the company could face near-term ...

To direct more attention toward the importance of regular breast cancer screenings, Novartis is taking to one of television’s ...

Over the years, the U.S. Department of Justice (DOJ) has taken a host of drugmakers to task over alleged kickback payments ...

Moderna and Novo Nordisk are once again in the bad books of the U.K.’s drug marketing watchdog. | Moderna and Novo Nordisk ...